| Literature DB >> 30111795 |
Elena Drosopoulou1, Dimitris Vlastos2, Ioanna Efthimiou2, Paraskevi Kyrizaki3, Sofia Tsamadou3, Maria Anagnostopoulou3, Danai Kofidou3, Maxim Gavriilidis3, Despoina Mademtzoglou3, Penelope Mavragani-Tsipidou3.
Abstract
Chios mastic products are well-known for their broad applications in food industry, cosmetics, and healthcare since the antiquity. Given our recent finding that Chios mastic water (CMW) exerts antigenotoxic action, in the present study, we evaluated the genotoxic as well as the antigenotoxic potential of the four major compounds of CMW, namely, verbenone, α-terpineol, linalool, and trans-pinocarveol. The cytokinesis block micronucleus (CBMN) assay in cultured human lymphocytes and the Drosophila Somatic Mutation And Recombination Test (SMART), also known as the wing spot test, were employed. None of the four major CMW's constituents or their mixtures showed genotoxic or recombinogenic activity in either of the assays used. Co-treatment of each of the constituents with MMC revealed that all except trans-pinocarveol exerted antigenotoxic potential. Moreover, co-administration of verbenone with linalool or α-terpineol presented statistically significant reduction of MMC-induced mutagenicity. In conclusion, the major CMW constituents were shown to be free of genotoxic effects, while some exerted antigenotoxic activity either alone or in combinations, suggesting synergistic phenomena. Our results provide evidence on the key antigenotoxicity effectors of the plant extract CMW.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30111795 PMCID: PMC6093890 DOI: 10.1038/s41598-018-29810-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Frequencies of BNMN and MN as well as CBPI values in cultured human lymphocytes treated with verbenone, α-terpineol, linalool, trans-pinocarveol alone or combined with mitomycin-C (MMC).
| Concentration ( | BNMN | MN | CBPI |
|---|---|---|---|
| 0 | 5.5 ± 1.5 | 5.5 ± 1.5 | 1.76 ± 0.04 |
| verbenone | |||
| 25 | 3.0 ± 0.0 | 3.0 ± 0.0 | 1.72 ± 0.021 |
| 50 | 2.5 ± 0.5 | 2.5 ± 0.5 | 1.60 ± 0.032 |
| 100 | 3.5 ± 0.5 | 3.5 ± 0.5 | 1.58 ± 0.062 |
| α-terpineol | |||
| 25 | 2.5 ± 0.5 | 2.5 ± 0.5 | 1.68 ± 0.102 |
| 50 | 3.0 ± 1.0 | 3.0 ± 1.0 | 1.66 ± 0.032 |
| 100 | 2.5 ± 0.5 | 2.5 ± 0.5 | 1.59 ± 0.052 |
| linalool | |||
| 25 | 3.0 ± 1.0 | 3.0 ± 1.0 | 1.74 ± 0.062 |
| 50 | 3.5 ± 0.5 | 3.5 ± 0.5 | 1.64 ± 0.002 |
| 100 | 4.5 ± 1.5 | 4.5 ± 1.5 | 1.59 ± 0.032 |
| trans-pinocarveol | |||
| 25 | 4.5 ± 1.5 | 4.5 ± 1.5 | 1.35 ± 0.042 |
| 50 | 2.5 ± 0.5 | 2.5 ± 0.5 | 1.34 ± 0.092 |
| 100 | 3.0 ± 0.0 | 3.5 ± 0.5 | 1.33 ± 0.012 |
| MMC | |||
| 0.05 | 65.5 ± 4.52 | 66.0 ± 5.02 | 1.52 ± 0.042 |
| verbenone + MMC | |||
| 25 + 0.05 | 58.5 ± 2.52 | 61.0 ± 1.02 | 1.38 ± 0.022,c |
| 50 + 0.05 | 45.5 ± 8.52,b | 46.5 ± 8.52,b | 1.45 ± 0.052 |
| 100 + 0.05 | 45.0 ± 7.02,b | 48.0 ± 10.02,a | 1.32 ± 0.042,c |
| α-terpineol + MMC | |||
| 25 + 0.05 | 32.5 ± 4.52,c | 33.0 ± 5.02,c | 1.34 ± 0.012,c |
| 50 + 0.05 | 45.0 ± 1.02,b | 45.5 ± 0.52,b | 1.33 ± 0.042,c |
| 100 + 0.05 | 45.0 ± 2.02,b | 46.0 ± 2.02,b | 1.29 ± 0.022,c |
| linalool + MMC | |||
| 25 + 0.05 | 48.0 ± 0.02,a | 49.5 ± 0.52,a | 1.35 ± 0.042,c |
| 50 + 0.05 | 56.0 ± 4.02 | 58.5 ± 1.52 | 1.31 ± 0.022,c |
| 100 + 0.05 | 41.0 ± 2.02,c | 42.5 ± 1.52,b | 1.42 ± 0.062,b |
| trans-pinocarveol + MMC | |||
| 25 + 0.05 | 63.0 ± 1.02 | 65.0 ± 1.02 | 1.19 ± 0.012,c |
| 50 + 0.05 | — | — | 1.09 ± 0.012,c |
| 100 + 0.05 | — | — | 1.07 ± 0.012,c |
BN: binucleated cells; BNMN: micronucleated binucleated cells; MN: micronuclei; CBPI: Cytokinesis Block Proliferation Index; MMC: Mitomycin-C; MF (‰) ± se, mean frequencies (‰) ± standard error; MN were scored in 2000 binucleated lymphocytes per experimental point;
1,2Significant difference compared to control at p < 0.01, and p < 0.001, respectively.
a,b,cSignificant difference compared to MMC at p < 0.05, p < 0.01, and p < 0.001 respectively; G-test for BNMN and MN; χ2 for CBPI.
Figure 1Reduction (%) of MN frequency induced by MMC (0.05 μg/ml) in the presence of different concentrations (25, 50, and 100 μg/ml) of verbenone, α-terpineol and linalool. *Significant difference compared to MMC.
Frequency of mutations (mosaic spots/wing) for each spot category (small, large, twin, and total) in D. melanogaster treated with Chios mastic water constituents (concentrations in μg/ml) alone or combined with mitomycin-C (MMC) in the Standard (ST) and High Bioactivation (HB) crosses.
| Concentration | Number of wings | Frequency of spots per wing and diagnosis1 | |||
|---|---|---|---|---|---|
| Small single spots | Large single spots | Twin spots | Total spots | ||
| ST cross | |||||
| 0 | 50 | 0.16 (8) | 0.06 (3) | 0.00 (0) | 0.22 (11) |
| verbenone | |||||
| 0.05 | 50 | 0.22 (11) i | 0.02 (1)− | 0.02 (1) i | 0.26 (13) i |
| 2.5 | 50 | 0.16 (8) i | 0.00 (0)− | 0.02 (1) i | 0.18 (9)− |
| α-terpineol | |||||
| 0.05 | 50 | 0.14 (7) i | 0.00 (0)− | 0.02 (1) i | 0.16 (8) − |
| 2.5 | 50 | 0.20 (10) i | 0.00 (0)− | 0.00 (0) i | 0.20 (10) i |
| linalool | |||||
| 0.025 | 50 | 0.20 (10) i | 0.06 (3) i | 0.02 (1) i | 0.28 (14) i |
| 2.5 | 50 | 0.12 (6) i | 0.04 (2)− | 0.00 (0) i | 0.16 (8)− |
| trans-pinocarveol | |||||
| 0.025 | 50 | 0.30 (15) i | 0.06 (3) i | 0.04 (2) i | 0.40 (20) i |
| 2.5 | 50 | 0.22 (11) i | 0.00 (0)− | 0.04 (2) i | 0.26 (13) i |
| MMC | |||||
| 2.5 | 50 | 0.54 (27)+ | 0.34 (17) + | 0.16 (8) + | 1.04 (52)+ |
| verbenone + MMC | |||||
| 0.05 + 2.5 | 50 | 0.38 (19)+ | 0.30 (15)+ | 0.24 (12)+ | 0.92 (46)+ |
| 2.5 + 2.5 | 50 | 0.36 (18)+ | 0.20 (10)+ | 0.00 (0) i * | 0.56 (28)+* |
| α-terpineol + MMC | |||||
| 0.05 + 2.5 | 50 | 0.36 (18)+ | 0.14 (7) i * | 0.10 (5)+ | 0.60 (30)+ |
| 2.5 + 2.5 | 50 | 0.48 (24)+ | 0.14 (7) i * | 0.06 (3) i | 0.68 (34)+ |
| linalool + MMC | |||||
| 0.025 + 2.5 | 50 | 0.42 (21)+ | 0.42 (21)+ | 0.10 (5)+ | 0.94 (27)+ |
| 2.5 + 2.5 | 50 | 0.42 (21)+ | 0.28 (14)+ | 0.06 (3) i | 0.76 (38)+ |
| trans-pinocarveol + MMC | |||||
| 0.025 + 2.5 | 50 | 0.70 (35)+ | 0.30 (15)+ | 0.14 (7)+ | 1.14 (57)+ |
| 2.5 + 2.5 | 50 | 0.52 (26)+ | 0.20 (10)+ | 0.06 (3) i | 0.78 (39)+ |
| HB cross | |||||
| 0 | 50 | 0.36 (18) | 0.06 (3) | 0.04 (2) | 0.46 (23) |
| verbenone | |||||
| 0.05 | 50 | 0.40 (20)− | 0.06 (3) i | 0.00 (0) − | 0.46 (23)− |
| 2.5 | 50 | 0.48 (24) i | 0.04 (2)− | 0.02 (1) i | 0.54 (27)− |
| α-terpineol | |||||
| 0.05 | 50 | 0.36 (18)− | 0.06 (3) i | 0.02 (1) i | 0.44 (22)− |
| 2.5 | 50 | 0.36 (18)− | 0.10 (5) i | 0.02 (1) i | 0.48 (24) − |
| linalool | |||||
| 0.025 | 50 | 0.48 (24) i | 0.00 (0)− | 0.02 (1) i | 0.50 (25)− |
| 2.5 | 50 | 0.26 (13) − | 0.00 (0)− | 0.00 (0)− | 0.26 (13)− |
| trans-pinocarveol | |||||
| 0 | 50 | 0.36 (18)− | 0.00 (0)− | 0.02 (1) i | 0.38 (19)− |
| 2.5 | 50 | 0.30 (15)− | 0.06 (3) i | 0.00 (0)− | 0.36 (18)− |
| MMC | |||||
| 2.5 | 50 | 0.86 (43)+ | 0.72 (36)+ | 0.26 (13) + | 1.84 (92)+ |
| verbenone + MMC | |||||
| 0.05 + 2.5 | 50 | 0.92 (46)+ | 0.52 (26)+ | 0.36 (18)+ | 1.80 (90)+ |
| 2.5 + 2.5 | 50 | 0.62 (31)+ | 0.28 (14) + * | 0.14 (7) i | 1.04 (52) + * |
| α-terpineol + MMC | |||||
| 0.05 + 2.5 | 50 | 0.54 (27) i | 0.44 (22) + * | 0.20 (10)+ | 1.18 (59)+ |
| 2.5 + 2.5 | 50 | 0.60 (30) i | 0.34 (17) + * | 0.10 (5) i | 1.04 (52) + * |
| linalool + MMC | |||||
| 0.025 + 2.5 | 50 | 0.88 (44)+ | 0.62 (31)+ | 0.26 (13)+ | 1.76 (88)+ |
| 2.5 + 2.5 | 50 | 0.80 (40) + | 0.98 (49)+ | 0.52 (26)+ | 2.30 (115)+ |
| trans-pinocarveol + MMC | |||||
| 0.025 + 2.5 | 50 | 0.84 (42)+ | 0.82 (41)+ | 0.28 (14)+ | 1.94 (97)+ |
| 2.5 + 2.5 | 50 | 0.84 (42)+ | 0.68 (34)+ | 0.56 (28)+ | 2.08 (104)+ |
1The number of mutant spots is given in parenthesis. Symbols next to values signify the following: +, positive mutagenic effect;−, no mutagenic effect; i, inconclusive effect (p = 0.05); Statistical diagnosis according to Frei and Würgler[50].
Frequency of mutations (mosaic spots/wing) for spot each category (small, large, twin, and total) in D. melanogaster treated with mixtures of Chios mastic water constituents (concentrations in alone or combined with mitomycin-C (MMC) (2.5 μg/ml) in the Standard (ST) and High Bioactivation (HB) crosses.
| Concentration | Number of wings | Frequency of spots per wing and diagnosis1 | |||
|---|---|---|---|---|---|
| Small single spots | Large single spots | Twin spots | Total spots | ||
| ST Cross | |||||
| 0 | 50 | 0.16 (8) | 0.06 (3) | 0.00 (0) | 0.22 (11) |
| verbenone + α-terpineol | |||||
| 0.05 + 0.05 | 50 | 0.24 (12) i | 0.00 (0)− | 0.08 (4) i | 0.32 (16) i |
| 2.5 + 2.5 | 50 | 0.10 (5)− | 0.02 (1)− | 0.00 (0) i | 0.12 (6)− |
| verbenone + linalool | |||||
| 0.05 + 0.025 | 50 | 0.16 (8) i | 0.00 (0)− | 0.00 (0) i | 0.16 (8) − |
| 2.5 + 2.5 | 50 | 0.20 (10) i | 0.00 (0)− | 0.04 (2) i | 0.24 (12) i |
| verbenone + trans-pinocarveol | |||||
| 0.05 + 0.025 | 50 | 0.12 (6) i | 0.00 (0)− | 0.00 (0) i | 0.12 (6)− |
| 2.5 + 2.5 | 50 | 0.12 (6) i | 0.14 (7) i | 0.02 (1) i | 0.28 (14) i |
| verbenone + α-terpineol + linalool + trans-pinocarveol | |||||
| 0.05 + 0.05 + 0.025 + 0.025 | 50 | 0.38 (19)+ | 0.00 (0)− | 0.00 (0) i | 0.38 (19) i |
| 2.5 + 2.5 + 2.5 + 2.5 | 50 | 0.14 (7) i | 0.08 (4) i | 0.00 (0) i | 0.22 (11) i |
| MMC | |||||
| 2.5 | 50 | 0.54 (27)+ | 0.34 (17)+ | 0.16 (8)+ | 1.04 (52)+ |
| verbenone + α-terpineol + MMC | |||||
| 0.05 + 0.05 + 2.5 | 50 | 0.50 (25) + | 0.72 (36)+ | 0.14 (7)+ | 1.36 (68)+ |
| 2.5 + 2.5 + 2.5 | 50 | 0.54 (27)+ | 0.10 (5) i | 0.10 (5)+ | 0.74 (37)+ |
| verbenone + linalool + MMC | |||||
| 0.05 + 0.025 + 2.5 | 50 | 0.26 (13) i | 0.32 (16)+ | 0.14 (7)+ | 0.72 (36)+ |
| 2.5 + 2.5 + 2.5 | 50 | 0.28 (14) i | 0.08 (4) i * | 0.00 (0) i * | 0.36 (18) i * |
| verbenone + trans-pinocarveol + MMC | |||||
| 0.05 + 0.025 + 2.5 | 50 | 0.36 (18)+ | 0.28 (14)+ | 0.14 (7)+ | 0.78 (39)+ |
| 2.5 + 2.5 + 2.5 | 50 | 0.48 (24)+ | 0.62 (31)+ | 0.20 (10)+ | 1.30 (65)+ |
| verbenone + terpineol + linalool + trans-pinocarveol + MMC | |||||
| 0.05 + 0.05 + 0.025 + 0.025 + 2.5 | 50 | 0.78 (39)+ | 0.50 (25)+ | 0.12 (6)+ | 1.40 (70)+ |
| 2.5 + 2.5 + 2.5 + 2.5 + 2.5 | 50 | 0.52 (26)+ | 0.26 (13)+ | 0.14 (7) + | 0.92 (46)+ |
| HB Cross | |||||
| 0 | 50 | 0.36 (18) | 0.06 (3) | 0.04 (2) | 0.46 (23) |
| verbenone + α-terpineol | |||||
| 0.05 + 0.05 | 50 | 0.40 (20)− | 0.06 (3) i | 0.04 (2) i | 0.50 (25)− |
| 2.5 + 2.5 | 50 | 0.30 (15)− | 0.00 (0)− | 0.00 (0)− | 0.30 (15)− |
| verbenone + linalool | |||||
| 0.05 + 0.025 | 50 | 0.20 (10)− | 0.10 (5) i | 0.04 (2) i | 0.34 (17)− |
| 2.5 + 2.5 | 50 | 0.30 (15)− | 0.02 (1)− | 0.04 (2) i | 0.36 (18)− |
| verbenone + trans-pinocarveol | |||||
| 0.05 + 0.025 | 50 | 0.44 (22) i | 0.06 (3) i | 0.00 (0)− | 0.50 (25)− |
| 2.5 + 2.5 | 50 | 0.24 (12)− | 0.00 (0)− | 0.06 (3) i | 0.30 (15)− |
| verbenone + α-terpineol + linalool + trans-pinocarveol | |||||
| 0.05 + 0.05 + 0.025 + 0.025 | 50 | 0.20 (10)− | 0.00 (0)− | 0.00 (0)− | 0.20 (10)− |
| 2.5 + 2.5 + 2.5 + 2.5 | 50 | 0.10 (5)− | 0.24 (12)+ | 0.02 (1) i | 0.36 (18)− |
| MMC | |||||
| 2.5 | 50 | 0.86 (43)+ | 0.72 (36)+ | 0.26 (13)+ | 1.84 (92)+ |
| verbenone + α-terpineol + MMC | |||||
| 0.05 + 0.05 + 2.5 | 50 | 0.50 (25) i | 0.26 (13) + * | 0.06 (3) i * | 0.82 (41) + * |
| 2.5 + 2.5 + 2.5 | 50 | 0.64 (32)+ | 0.48 (24) + | 0.16 (8) i | 1.28 (64)+ |
| verbenone + linalool + MMC | |||||
| 0.05 + 0.025 + 2.5 | 50 | 0.12 (6) + * | 0.30 (15) + * | 0.00 (0) − * | 0.42 (21)− * |
| 2.5 + 2.5 + 2.5 | 50 | 0.14 (7) + * | 0.12 (6) i * | 0.02 (1) i * | 0.28 (14)− * |
| verbenone + trans-pinocarveol + MMC | |||||
| 0.05 + 0.025 + 2.5 | 50 | 0.82 (41)+ | 0.56 (28)+ | 0.18 (9)+ | 1.56 (44)+ |
| 2.5 + 2.5 + 2.5 | 50 | 0.90 (45)+ | 0.82 (41)+ | 0.32 (16)+ | 2.04 (102)+ |
| verbenone + terpineol + linalool + trans-pinocarveol + MMC | |||||
| 0.05 + 0.05 + 0.025 + 0.025 + 2.5 | 50 | 0.30 (15)− | 0.54 (27)+ | 0.14 (7) i | 0.98 (49)+* |
| 2.5 + 2.5 + 2.5 + 2.5 + 2.5 | 50 | 0.10 (5)+* | 0.24 (12)+* | 0.02 (1) i * | 0.36 (18)− * |
1The number of mutant spots is given in parenthesis. Symbols next to values signify the following: + , positive mutagenic effect; −, no mutagenic effect; i, inconclusive effect (p = 0.05); Statistical diagnosis according to Frei and Würgler[50].